Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T21:57:52.689Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T21:57:52.689Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 94b5ad3735cc71b9af2236876c301d5f64b1c42b83610b62f031870796dba4d5
FORWARD PE RATIO
N/A
Polyrizon Ltd.
Market Cap
$10.83M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Polyrizon Ltd. (PLRZ) | $10.83M | N/A |
| BioVie Inc. (BIVI)vs › | $10.86M | N/A |
| Cerenome, Inc. (CNSY)vs › | $10.94M | N/A |
| Pluri Inc. (PLUR)vs › | $10.68M | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.00M | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $11.02M | N/A |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.08M | N/A |
| VistaGen Therapeutics, Inc. (VTGN)vs › | $11.12M | N/A |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | N/A |
| Caring Brands, Inc. (CABR)vs › | $11.36M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
